ELAB NASDAQ
PMGC Holdings Inc.
1W: -26.5%
1M: -34.0%
3M: -74.9%
YTD: -99.8%
1Y: -99.9%
$3.36
+0.14 (+4.19%)
Weekly Expected Move ±14.5%
$2
$3
$3
$4
$4
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
37 relationships35
As Filer
counterparties named
2
As Counterparty
mentioned by others
4
Rel. Types
2023-12-04
Earliest Filing
2026-03-27
Latest Filing
partner: 23
target: 5
acquirer: 5
investor: 2
Counterparties (Filed by ELAB)
35 relationshipsCompanies named in ELAB's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Northstrive Biosciences Inc. | — | partner | Wholly owned subsidiary of PMGC Holdings Inc. that entered into a Third Amendment to a License Agreement. | 2026-03-27 | View |
| MOA Life Plus Co., Ltd. | — | partner | Korean corporation that entered into a Third Amendment to a License Agreement with Northstrive Biosciences Inc. | 2026-03-27 | View |
| Northstrive Companies Inc | — | partner | Consulting and Services Agreement for Non-Employee, Non-Executive Chairman | 2026-03-23 | View |
| GB Capital Ltd | — | partner | Consulting and Services Agreement for Non-Employee Chief Executive Officer | 2026-03-23 | View |
| SVM Machining, Inc. | — | target | Target company acquired 100% of its issued and outstanding shares by PMGC Holdings Inc. | 2026-02-06 | View |
| Indarg Engineering, Inc. | — | target | Sold assets and assumed liabilities to AGA Precision Systems LLC. | 2025-10-30 | View |
| AGA Precision Systems LLC | — | acquirer | Acquired assets and assumed liabilities from Indarg Engineering, Inc. | 2025-10-30 | View |
| GB Capital Ltd | — | partner | Counterparty to secondment and consulting agreements for executive services | 2025-10-21 | View |
| Northstrive Companies Inc | — | partner | Counterparty to secondment and consulting agreements for executive services | 2025-10-21 | View |
| Northstrive Companies Inc. | — | partner | Consulting agreement partner for Non-Executive Chairman | 2025-08-18 | View |
| GB Capital Ltd | — | partner | Consulting agreement partner for Non-Employee Chief Executive Officer | 2025-08-18 | View |
| GB Capital Ltd | — | partner | GB Capital Ltd entered into a Secondment Agreement to provide employees to PMGC Holdings Inc. | 2025-07-31 | View |
| AGA Precision Systems LLC | — | target | Target company acquired 100% of its membership units by PMGC Holdings Inc. | 2025-07-22 | View |
| Pacific Sun Packaging Inc. | — | target | Target of acquisition by PMGC Holdings Inc. | 2025-07-11 | View |
| MOA Life Plus Co., Ltd. | — | partner | Korean corporation amending license agreement with Northstrive Biosciences Inc. | 2025-05-16 | View |
| Northstrive Biosciences Inc. | — | partner | Wholly owned subsidiary of PMGC Holdings Inc. entering license agreements. | 2025-05-16 | View |
| Modulant Biosciences LLC | — | partner | Entity entering binding term sheet for future licensing agreement with Northstrive Biosciences Inc. | 2025-05-16 | View |
| Northstrive Companies Inc. | — | partner | Secondment agreement to provide employees to PMGC Holdings Inc. | 2025-05-13 | View |
| GB Capital Ltd | — | partner | Consulting agreement partner for Non-Employee Chief Executive Officer | 2025-04-08 | View |
| Northstrive Companies Inc. | — | partner | Consulting agreement partner for Non-Executive Chairman | 2025-04-08 | View |
| GB Capital Ltd. | — | investor | Recipient of Series B Preferred Stock signing bonus | 2025-03-27 | View |
| Northstrive Companies Inc. | — | investor | Recipient of Series B Preferred Stock signing bonus | 2025-03-27 | View |
| MOA Life Plus Co., Ltd. | — | partner | Licensee in the Amended License Agreement with Northstrive Biosciences | 2025-03-27 | View |
| Cutis Cura Corporation | — | acquirer | Acquired skincare and haircare assets from PMGC Holdings Inc. for stock, liability assumption, and cash | 2025-01-17 | View |
| Carmell Corporation | CTCX | acquirer | Nasdaq-listed company that issued common stock to the Seller as part of the asset purchase agreement | 2025-01-17 | View |
| Cutis Cura Corporation | — | acquirer | Purchased substantially all assets of Elevai Skincare and PMGC Holdings Inc. | 2025-01-07 | View |
| Carmell Corporation | — | acquirer | Sole stockholder of Cutis Cura Corporation; issued stock and made cash payments as consideration. | 2025-01-07 | View |
| Elevai Skincare Inc. | — | target | Wholly owned subsidiary of PMGC Holdings Inc. whose assets were sold in the transaction. | 2025-01-07 | View |
| GB Capital Ltd | — | partner | Consulting agreement for Non-Employee Chief Executive Officer | 2024-10-31 | View |
| Northstrive Companies Inc. | — | partner | Consulting agreement for Non-Executive Chairman | 2024-10-31 | View |
| KCRN Research, Inc. | — | partner | Entered into a Master Services Agreement to provide clinical and regulatory services for an IND application. | 2024-10-25 | View |
| Santorio Biomedical, LLC | — | partner | Consulting agreement for services of Mr. Deniel Mero | 2024-05-09 | View |
| MOA Life Plus Co., Ltd. | — | partner | Exclusive license agreement for commercialization of engineered probiotic products | 2024-05-02 | View |
| INmune Bio, Inc. | INMB | partner | Elevai Labs entered into a License Agreement to obtain exclusive and non-exclusive rights to develop, manufacture, and c | 2024-01-22 | View |
| Yuva BioSciences, Inc. | — | partner | Collaboration and license agreement for developing and commercializing cosmetic products containing Yuva's proprietary c | 2023-12-04 | View |
Mentioned As Counterparty
2 mentionsOther companies that named ELAB in their SEC 8-K filings.
| Filed By | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|
| XAGEW Carmell Corp | target | Parent company of Elevai Skincare, Inc. that entered into an asset purchase agreement with Carmell Corporation. | 2025-01-16 | View |
| XAGEW Carmell Corp | acquirer | Nevada corporation and successor to Elevai Labs Inc., selling assets to Cutis Cura Corporation. | 2025-01-03 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-18 | Regulation FD; Exhibits | View | |
| 2026-09-02 | Material Agreement; Bylaws Amendment; Regulation FD; Exhibits | Agreement | View |
| 2026-08-27 | Material Agreement; Bylaws Amendment; Regulation FD; Other Events; Exhibits | Agreement | View |
| 2026-07-09 | Material Agreement; Exhibits | Agreement | View |
| 2026-07-07 | Material Agreement; Exhibits | Agreement | View |
| 2026-07-01 | Regulation FD; Exhibits | View | |
| 2026-06-08 | Bylaws Amendment; Shareholder Vote; Exhibits | View | |
| 2026-06-05 | Material Agreement; Exhibits | Agreement | View |
| 2026-05-13 | Material Agreement; Acquisition/Disposition; Regulation FD; Exhibits | Agreement Acquisition | View |
| 2026-04-28 | Regulation FD; Exhibits | View | |
| 2026-04-23 | Regulation FD; Exhibits | View | |
| 2026-04-21 | Regulation FD; Exhibits | View | |
| 2026-04-17 | Material Agreement; Unregistered Equity Sales; Regulation FD; Exhibits | Agreement | View |
| 2026-04-09 | Regulation FD; Exhibits | View | |
| 2026-04-08 | Regulation FD; Exhibits | View | |
| 2026-04-06 | Regulation FD; Exhibits | View | |
| 2026-04-02 | Regulation FD; Exhibits | View | |
| 2026-03-31 | Regulation FD; Exhibits | View | |
| 2026-03-27 | Material Agreement; Exhibits | Agreement | View |
| 2026-03-24 | Regulation FD; Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR